|
(ÁÖ)´ÙÀ̾Ƶ§Æ® |
(ÁÖ)´ÙÀ̾Ƶ§Æ® ÁøÃëÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀλçÃѹ« Á÷¿ø ¸ðÁý
ÃæºÏ û¿ø±º | ´ëÇÐ(2~3³â) Á¹¾÷ |
Àλç/ÀÎÀç°³¹ß/ä¿ë/±³À° |
2³â¡è |
ä¿ë½Ã |
03.04 |
|
|
°æ¹æ½Å¾àÁÖ½Äȸ»ç |
°æ¹æ½Å¾à(ÁÖ) µðÀÚÀÎÆÀ Á÷¿øÀ» ¸ðÁýÇÕ´Ï´Ù.
ÀÎõ ³²µ¿±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦Ç°/»ê¾÷µðÀÚÀÎ |
2³â¡è |
ä¿ë½Ã |
03.02 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CTA I/II, Sr.CTA
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CTA/CRC |
1³â¡è |
ä¿ë½Ã |
03.02 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CRA I/II
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
03.02 |
|
|
(ÁÖ)¿¡½º¾ØÁö¹ÙÀÌ¿ÀÅØ |
ÀüÇ¥ÀÔ·Â&±âÀ塤ÀåºÎÁ¤¸®&´õÁ¸ ¿Ü Á¤±ÔÁ÷ ¸ðÁý °ø°í - °æ·Â
°æ±â ¿ëÀνà | °íµîÇб³ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
2³â¡è |
ä¿ë½Ã |
02.26 |
|
|
Á¦³ë¸¶ÀÎ(ÁÖ) |
Á¦³ë¸¶ÀÎ(ÁÖ) ±â°£Á¦ °æ¸®»ç¹«¿ø ¸ðÁý
°æºÏ Æ÷Ç׽à ³²±¸ | Çз¹«°ü |
»ç¹«/Ãѹ«/¹ý¹«/ƯÇã |
1³â¡è |
ä¿ë½Ã |
02.16 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CTA I/II, Sr.CTA
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CTA/CRC |
1³â¡è |
ä¿ë½Ã |
02.08 |
|
|
(ÁÖ)ÀÌÁö¼Ö·çÅØ |
GMPÀÎÁõ ÄÁ¼³ÅÏÆ® ¸ðÁý(ÀÇ·á±â±â)
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
¼ö½Ãä¿ë |
2³â¡è |
ä¿ë½Ã |
02.04 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] PV Associate ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
2³â¡è |
ä¿ë½Ã |
01.29 |
|
|
(ÁÖ)±×¸°Á¦¾à |
(ÁÖ)±×¸°Á¦¾à Áß¾Ó¿¬±¸¼Ò °æ·Â»ç¿ø ¸ðÁý
ÃæºÏ û¿ø±º | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
2³â¡è |
ä¿ë½Ã |
01.21 |
|
|
Çѱ¹Organon |
Çѱ¹Organon Market Access ´ã´çÀÚ ¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
1³â¡è |
ä¿ë½Ã |
01.15 |
|
|
(ÁÖ)¶õµ¶½ºÄÚ¸®¾Æ |
¶õµ¶½ºÄÚ¸®¾Æ RA QA °æ·Â Á¤±ÔÁ÷ ü¿ÜÁø´Ü¿ë½Ã¾à ¿µ±¹Áö»ç
°æ±â ¾È¾ç½Ã µ¿¾È±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
1³â¡è |
ä¿ë½Ã |
01.07 |
|
|
Çѱ¹º¤Å©¸¸ÄðÅÍ |
Çѱ¹º¤Å©¸¸ÄðÅÍ Clinical IT Specialist °æ·ÂÁ÷ ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¼¹ö/º¸¾È/³×Æ®¿öÅ©/LAN |
1³â¡è |
ä¿ë½Ã |
01.05 |
|
|
(ÁÖ)³Ø½ºÁ¨¹ÙÀÌ¿ÀÅØ |
³Ø½ºÁ¨¹ÙÀÌ¿ÀÅØ µðÁöÅÐ È«º¸ Àü¹®°¡ ¸ðÁý
¼¿ï ±Ýõ±¸ | Çз¹«°ü |
±¤°í/È«º¸/PR/»çº¸ |
1³â¡è |
ä¿ë½Ã |
01.04 |
|
|
(ÁÖ)¿ÍÀ̵ð»ý¸í°úÇÐ |
¿ÍÀ̵ð»ý¸í°úÇÐ [¿¡ÀÏ·Ð] °æ¿µÁö¿ø °æ·ÂÁ÷ ä¿ë
°æ±â ¼º³²½Ã Áß¿ø±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
1³â¡è |
ä¿ë½Ã |
12.21 |
|